reference/31511577

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31511577

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1674
issn	1538-7445 0008-5472
issueIdentifier	3
pageRange	1664-1674
publicationName	Cancer Research
startingPage	1664
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2c5e0d15f365cae77311245a30860142
bibliographicCitation	Emmenegger U, Morton GC, Francia G, Shaked Y, Franco M, Weinerman A, Man S, Kerbel RS. Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia. Cancer Res. 2006 Feb 01;66(3):1664–74. doi: 10.1158/0008-5472.can-05-2598. PMID: 16452226.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36aa0b339fb9091c2dd3ae7116099019 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c00b59efd5770f1dfce87c1a8690c126 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9f14c475d0e7a3cba956daef4b0304a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a283a63e28b319b6f5c2789501563a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99fe0b86e14e2ac5de56c266901541af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13972c3facf8c40d701628c1f4308122 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef2d203ccca7d3239fadfa62a99889ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f289bc39ad761e314fe3b34d72fd138
date	2006-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16452226 https://doi.org/10.1158/0008-5472.can-05-2598
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786 https://portal.issn.org/resource/ISSN/1538-7445 https://portal.issn.org/resource/ISSN/0008-5472
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Low-Dose Metronomic Daily Cyclophosphamide and Weekly Tirapazamine: A Well-Tolerated Combination Regimen with Enhanced Efficacy That Exploits Tumor Hypoxia
discusses	http://id.nlm.nih.gov/mesh/M0021908 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0015671 http://id.nlm.nih.gov/mesh/M0142901
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D009369Q000378 http://id.nlm.nih.gov/mesh/D000971Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D000971Q000633 http://id.nlm.nih.gov/mesh/D001943Q000098 http://id.nlm.nih.gov/mesh/D009389Q000188 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D009369Q000473 http://id.nlm.nih.gov/mesh/D000077704 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D003520Q000633 http://id.nlm.nih.gov/mesh/D010100Q000378 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011471Q000098 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D003110Q000473 http://id.nlm.nih.gov/mesh/D014227Q000633 http://id.nlm.nih.gov/mesh/D003110Q000378 http://id.nlm.nih.gov/mesh/D009389Q000473 http://id.nlm.nih.gov/mesh/D011471Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015687Q000502 http://id.nlm.nih.gov/mesh/D003110Q000188 http://id.nlm.nih.gov/mesh/D014227Q000008 http://id.nlm.nih.gov/mesh/D048708Q000187 http://id.nlm.nih.gov/mesh/D001943Q000378 http://id.nlm.nih.gov/mesh/D009369Q000098 http://id.nlm.nih.gov/mesh/D003110Q000098 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6914 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a8bd9503aa2b9fdf4fb06029687b8bce http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413511 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135788062

Total number of triples: 80.